Substance / Medication

Penbutolol

Overview

Active Ingredient
penbutolol
RxNorm CUI
7973

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

2 trials linked to this intervention

2
Total Trials
0
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Intensive Blood Pressure Control in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cardiovascular and Microvascular Outcomes.
Mousavi Asma, Shojaei Shayan, Abhari Amir Parsa et al. · Am J Hypertens · 2026
PMID: 40717314Meta-Analysis
The Effect of SGLT2 Inhibitors on Blood Pressure in Relation to Baseline Kidney Function: A Systematic Literature Review and Data Analysis.
Møller Charlotte Agergaard, Nielsen Steffen Flindt, Mose Frank Holden · Am J Hypertens · 2026
PMID: 40717316Meta-Analysis
Arterial spin labeling MRI in assessing cerebral blood flow changes due to hypertension: a systematic review.
Muthu Sathya Sabina, Sukumar Suresh, Kadavigere Rajagopal et al. · J Hypertens · 2026
PMID: 41002015Meta-AnalysisFull text (PMC)
The intergenerational effects of low parental socio-economic position on cardiometabolic and inflammatory outcomes: A systematic review and meta-analysis.
Rivillas-García Juan Carlos, Courtin Emilie, Winpenny Eleanor et al. · Eur J Clin Invest · 2026
PMID: 41020493Meta-AnalysisFull text (PMC)
Intake of coffee and blood pressure: A Mendelian randomized study.
Zhong Jiwen, Huang Sichao, Dong Shaohong et al. · Nutr Metab Cardiovasc Dis · 2026
PMID: 41087205Meta-Analysis
Angiotensin receptor neprilysin inhibitor for the treatment of hypertension: a systematic review and meta-analysis.
Noe Hsu Myat, Sujarit Alisara Sangviroon, Chongmelaxme Bunchai et al. · Hypertens Res · 2026
PMID: 41145713Meta-Analysis
Influence of sonophoresis and chemical penetration enhancers on percutaneous transport of penbutolol sulfate.
Ita Kevin B, Popova Inna E · Pharm Dev Technol · 2016
PMID: 26383739Preclinical
In vitro transdermal iontophoretic delivery of penbutolol sulfate.
Ita K B, Banga A K · Drug Deliv · 2009
PMID: 19555303Preclinical
High-performance liquid chromatography with chemiluminescence detection of penbutolol and its hydroxylated metabolite in rat plasma.
Funato K, Imai T, Nakashima K et al. · J Chromatogr B Biomed Sci Appl · 2001
PMID: 11417867Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Penbutolol (substance)
SNOMED CT
372505004
UMLS CUI
C0030812
RxNorm CUI
7973

Clinical Data

This intervention maps to 9 entities in the Healos knowledge graph.

3
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
2
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Penbutolol — Conditions, Biomarkers & Specialists | Healos | Healos